DOCSLIB.ORG

HEALTH + Registered Offi Ce Helping People Look Alliance Boots Gmbh and Feel Their Best Baarerstrasse 94 CH-6300 Zug Switzerland

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
HEALTH + Registered Offi Ce Helping People Look Alliance Boots Gmbh and Feel Their Best Baarerstrasse 94 CH-6300 Zug Switzerland Alliance Boots Boots Alliance Annual Report 2010/11 Annual For more information www.allianceboots.com HEALTH + Registered offi ce Helping people look Alliance Boots GmbH and feel their best Baarerstrasse 94 CH-6300 Zug Switzerland Contact [email protected] Alliance Boots Annual Report 2010/11 Overview Our performance in 2010/11 Glossary of key terms (for the year ended 31 March 2011) Constant currency Like for like revenue Trading profit Exchange rates applicable for the financial Like for like revenue on a constant currency basis Profit from operations before amortisation of information for the year ended 31 March 2010. compared to the comparable period in the customer relationships and brands, exceptional previous year. items and share of post tax earnings of EBITDA associates and joint ventures. Trading profit before underlying depreciation Net borrowings Revenue EBITDA Trading profit and amortisation. Cash and cash equivalents, restricted cash, Underlying depreciation and amortisation derivative financial instruments and borrowings Depreciation and amortisation adjusted to Exceptional items net of unamortised prepaid financing fees. exclude amortisation of customer relationships Items classified by Alliance Boots as exceptional and brands and depreciation and amortisation in nature. These are not regarded as forming Net finance costs within exceptional items. +15.1% +10 . 8 % +14 . 2 % part of the underlying trading activities of the Finance costs net of finance income. Group and so merit separate presentation to Underlying net finance costs allow stakeholders to understand the elements Restricted cash Net finance costs adjusted to exclude of financial performance and assess trends in Cash which is restricted for specific purposes exceptional items and timing differences within financial performance. and so is not available for the use of the Group net finance costs. £20.2bn £1,300m £1,051m in its day to day operations. £23.3 billion including share of associates £1,442 million including share of associates £1,164 million including share of associates IAS 39 timing differences Underlying profit Derivative financial instruments are used to Share of underlying post tax earnings Profit for the year before amortisation of and joint ventures and joint ventures and joint ventures hedge interest rate and currency exposures. of associates and joint ventures customer relationships and brands, exceptional IAS 39 dictates whether changes in the fair value Share of post tax earnings of associates and items, timing differences within net finance of these instruments can be matched in the joint ventures before amortisation of customer costs and related tax. income statement by changes in the fair value of relationships and brands, exceptional items, F 1&%#,#02#"$0-+-.#02'-,1ylAnkt+'**'-, the item being hedged. Where they cannot be timing differences within net finance costs Underlying tax charge/credit F#2 -00-5',%10#"3!#" 7ypoq+'**'-, matched, or do not fully match, the unmatched and related tax. Tax charge/credit adjusted to exclude tax on amount represents a timing difference that will amortisation of customer relationships and F 2#.!&,%#',',2#0,2'-,*#6.,1'-,-$.&0+!#32'!*5&-*#1*',%B reverse over the life of the financial instruments. Timing differences within net brands, exceptional items, timing differences – Controlling interest in Hedef Alliance acquired in July (Turkey, Egypt) finance costs within net finance costs and exceptional tax. Interest cover IAS 39 timing differences and the unwind of – ANZAG majority ownership acquired in December (Germany, Romania, Lithuania) Trading profit divided by underlying net the discount on obligations to non controlling F ,2#0,2'-,*'12'-,-$.0-"3!2 0,"1!!#*#02',% finance costs. interests. Trading margin 1 EBITDA comprises trading profit before underlying Trading profit expressed as a percentage £million depreciation and amortisation. of revenue. Revenue 20,218 2 Underlying depreciation and amortisation excludes amortisation of customer relationships and brands and EBITDA1 1,300 depreciation and amortisation within exceptional items. 2 3 Trading profit comprises profit from operations before Underlying depreciation and amortisation (249) amortisation of customer relationships and brands, 3 exceptional items and share of post tax earnings of Trading profit 1,051 associates and joint ventures. Associates and joint ventures – share of underlying post tax earnings4 74 4 Associates and joint ventures – share of underlying post tax earnings comprises share of post tax earnings of associates 5 Alliance Boots GmbH This Report is printed on Heaven 42 paper that has Underlying net finance costs (381) and joint ventures before amortisation of customer Copyright and trade mark notices been independently certified on behalf of the Forest relationships and brands, exceptional items, timing 6 Underlying tax charge (137) differences within net finance costs and related tax. All rights reserved Stewardship Council (FSC). 7 5 Underlying net finance costs comprise net finance costs © Copyright 2011 Alliance UniChem IP Limited Underlying profit 607 adjusted to exclude exceptional items and timing Printed at St Ives Westerham Press Ltd, ISO9001, differences within net finance costs. BOOTS, SOLTAN, SOLEI SP, No7, 17, BOOTS ISO14001, FSC certified and CarbonNeutral® 6 Underlying tax charge excludes tax on amortisation of PHARMACEUTICALS, PROTECT & PERFECT INTENSE 0#!-,!'*'2'-,-$3,"#0*7',%.0-i22-12232-07.0-i2$-02&#7#0'11#2-32 #*-5B customer relationships and brands, exceptional items, timing differences within net finance costs and exceptional tax. BEAUTY SERUM, No7 PROTECT & PERFECT INTENSE £million 7 Underlying profit excludes amortisation of customer DAY CREAM, BOTANICS, BOOTS LABORATORIES, relationships and brands, exceptional items, timing 7 SERUM7, YOUR LOCAL BOOTS PHARMACY, BOOTS Underlying profit 607 differences within net finance costs and related tax. OPTICIANS, BOOTSWEBMD, BOOTS ADVANTAGE 8 Net exceptional items before tax mainly comprised a net CARD, TREAT STREET, BOOTS EMPLOYEE WELLBEING Amortisation of customer relationships and brands (114) gain in relation to the closure of a number of defined SERVICE, BOOTS IRELAND, BOOTS THAILAND, BOOTS Net exceptional items before tax8 36 benefit pension schemes offset by costs in relation to a restructuring programme in the UK part of the Health & APOTEK and BOOTS APOTHEEK are trade marks owned by The Boots Company PLC. Timing differences within net finance costs (29) Beauty Division and the second phase of the restructuring Designed and produced by programme in the Pharmaceutical Wholesale Division. CONRAN DESIGN GROUP Tax credit on items not in underlying profit 40 9 Exceptional tax credit related to the net reduction in ALMUS, ALVITA, ALLOGA, ALLIANCE HEALTHCARE 9 deferred tax assets and liabilities resulting from the two and ALLIANCE HEALTHCARE (DISTRIBUTION) are Exceptional tax credit 72 percentage point reduction in the rate of UK corporation Registered office trade marks owned by Alliance UniChem IP Limited. Profit from continuing operations 612 tax applicable from April 2011. Alliance Boots GmbH Baarerstrasse 94 ALPHEGA PHARMACY is a trade mark owned by Profit from discontinued operations 3 CH-6300 Zug Alliance Healthcare France Société Anonyme. Profit for the year 615 Switzerland VIVESCO and VIVESCO APOTHEKEN are owned by Contact Andreae-Noris Zahn AG [email protected] Website www.allianceboots.com Alliance Boots | Annual Report 2010/11 113 Overview Business review Governance Consolidated Additional information financial statements We are a leading international, pharmacy-led health and beauty group. Our focus is on helping people look and feel their best. HEALTH + What’s inside Overview 00 Our performance in 2010/11 02 Our Group at a glance 03 Our mission, purpose and values 04 Our business activities 06 Executive Chairman’s statement 10 Group strategy and objectives 14 Our markets and business environment Business review 18 Overview 22 Health & Beauty Division 28 Pharmaceutical Wholesale Division 34 Other activities 36 Financial review 42 Performance measures 43 Financial record 44 Risk management 46 Our people 47 Corporate social responsibility Governance 50 Board of Directors 52 Board report on corporate governance 54 Board report on remuneration 57 Audit committee report Consolidated fi nancial statements 58 Directors’ responsibilities statement 59 Statutory auditor’s report 60 Group income statement 60 Group statement of comprehensive income 61 Group statement of fi nancial position 62 Group statement of changes in equity 63 Group statement of cash fl ows 64 Notes to the consolidated fi nancial statements Additional information 110 Principal businesses, associates and joint ventures 113 Glossary of key terms Alliance Boots | Annual Report 2010/11 01 Overview Our Group at a glance Alliance Boots is a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Working in close partnership with manufacturers and pharmacists, we are committed to improving health in the local communities we serve and helping our customers and patients to look and feel their best. Our focus is on growing our two core business activities: F&0+!7Q*#"&#*2&," #3270#2'*',% F&0+!#32'!*5&-*#1*',%,""'120' 32'-, Over 115,500* employees 0#1#,!#',-4#0mp?!-3,20'#1 Dispensing more than 250 million* items each year 115,500+ 25+ 250m+ Operating more than 3,280* Delivering to over 160,000* Operating over 370* health & beauty retail stores, pharmacies,
Load more

Recommended publications
  • Contents Page
    Statement of Development Principles: Regeneration Of Boots Campus, Beeston, Nottingham June 2007 STATEMENT OF DEVELOPMENT PRINCIPLES: REGENERATION OF BOOTS CAMPUS, BEESTON, NOTTINGHAM (June 2007) Contents 1. Introduction................................................................................................2 PURPOSE.............................................................................................................................. 2 POLICY CONTEXT................................................................................................................ 3 2. Development Principles ............................................................................4 THE VISION........................................................................................................................... 4 KEY DEVELOPMENT PRINCIPLES ..................................................................................... 4 3. Key Issues ..................................................................................................7 HIGHWAYS AND ACCESS ................................................................................................... 7 BALANCE OF USES ............................................................................................................. 7 LISTED BUILDINGS .............................................................................................................. 9 ENVIRONMENT.....................................................................................................................9
    [Show full text]
  • All Together. Different. Svi Zajedno
    Diversity & Inclusion Report 2018–19 All Together. Different. Svi zajedno. Različiti. • Všichni společně. • Každý jiný. • Eensgezind. Anders. • Tous ensem- ble, tous différents. • Einträchtig. Anders. • Tut- ti assieme, ma diversi. • Visi kartu. Skirtingi. • Alle sammen. Forskjellige • Todos juntos. TableDifer of Contents- Deepening Our Diversity and Inclusion entes. • Împreună. Diferiți • Hep birlikte. FaEmphasisrklı. ............................................... 1 • Svi zajedno. Različiti. • Všichni společněMessages. • from Our CEO, Global Chief Human Resources Officer and Our Global Každý jiný. • Eensgezind. Anders. • Tous enChief -Diversity Officer ........................2–3 Our D&I Impact Is Expansive semble, tous différents. • Einträchtig. Anderand Expandings. • ...................................... 4 WBA Strengthens Its D&I Strategy, Tutti assieme, ma diversi. • Visi kartu. SkirtiData Collectionngi. ............................... 6–13 Our Business Resource Groups Foster Inclusive Global Cultures ................ 14–21 All Together. Different. Împreună. Diferiți • Expanding Business Opportunities Todos juntos. Diferentes. • Hep birlikte. Farklby Attracting,ı. Nurturing Diverse Suppliers .......................... 22–25 • Svi zajedno. Različiti. • Všichni společně.WBA • Earns Wide Recognition for D&I Leadership ........................ 26–27 Každý jiný. • Eensgezind. Anders. • Tous ensemLooking Ahead ....................................- 29 ble, tous différents. • Einträchtig. Anders. • Tut- ti assieme, ma diversi. • Visi kartu.
    [Show full text]
  • Corporate Social Responsibility Report 2016 Walgreens Boots Alliance Is the First Global Pharmacy-Led, Health and Wellbeing Enterprise
    Corporate Social Responsibility Report 2016 Walgreens Boots Alliance is the first global pharmacy-led, health and wellbeing enterprise. Our purpose is to help people across the world lead healthier and happier lives. Our 2016 Corporate Social Responsibility Report covers the fiscal year that ended 31 August 2016. In this year’s report: Overview Marketplace Introduction ...................................................1 Our CSR goals .............................................2 28 Our vision, purpose and values ................3 Our approach to CSR .................................4 Contributing to the United Nations Sustainable Development Goals .............6 Transparency ........................................... 30 Our impact ...................................................8 Ethical Sourcing ...................................... 30 ........................... About our Company ................................. 10 External Stakeholders 31 Stakeholder engagement ....................... 12 Workplace Community 32 14 Employee Health and Wellbeing ........ 34 Equal Opportunities .............................. 36 Health and Wellbeing ............................. 16 Health and Safety ...................................37 Young People ........................................... 17 ...................................... Cancer Programs .....................................20 About this report 38 Data management process ................ 38 Environment Data ............................................................ 38 Community data
    [Show full text]
  • ANGEBOTSUNTERLAGE Freiwilliges Öffentliches
    Pflichtveröffentlichung gemäß §§ 34, 14 Abs. 2 und 3 Wertpapiererwerbs- und Übernahmegesetz (WpÜG) Aktionäre der WMF Württembergische Metallwarenfabrik Aktiengesellschaft, insbesondere mit Wohnsitz, Sitz oder gewöhnlichem Aufenthalt außerhalb der Bundesrep ublik Deutschland, sollten die Hinweise in Abschnitt 1 "Allgemeine Hinweise, insbesondere für Aktionäre mit Wohnsitz, Sitz oder gewöhnlichem Aufenthalt außerhalb der Bundesrepublik Deutschland" auf den Seiten 4 ff. dieser Angebotsunterlage sowie in Abschnitt 23 "Wichtige Hinweise für US-Aktionäre" auf den Sei- ten 48 ff. dieser Angebotsunterlage besonders beachten. ANGEBOTSUNTERLAGE Freiwilliges öffentliches Übernahmeangebot (Barangebot) der Finedining Capital GmbH Leopoldstraße 8-10, 80802 München, Deutschland an die Aktionäre der WMF Württembergische Metallwarenfabrik Aktiengesellschaft Eberhardstraße 17-47, 73309 Geislingen an der Steige, Deutschland zum Erwerb ihrer auf den Inhaber lautenden Stammaktien und ihrer auf den Inhaber lautenden Vor- zugsaktien an der WMF Württembergische Metallwarenfabrik Aktiengesellschaft gegen Zahlung einer Geldleistung in Höhe von EUR 47,00 je Stammaktie und EUR 31,80 je Vorzugsaktie der WMF Württembergische Metallwarenfabrik Aktiengesellschaft Die Annahmefrist läuft vom 16. August 2012 bis 20. September 2012, 24:00 Uhr (Ortszeit Frankfurt am Main) / 18:00 Uhr (Ortszeit New York) Aktien der WMF Württembergische Metallwarenfabrik Aktiengesellschaft: International Securities Identification Number (ISIN) DE0007803009 (Stammaktien) und DE0007803033 (Vorzugsaktien)
    [Show full text]
  • Helping People Look and Feel Their Best Alliance Boots Annual Report 2013/14 We Are a Leading International Pharmacy-Led Health and Beauty Group
    Alliance Boots Alliance Annual Report 2013/14 Report Annual Helping people look and feel their best Alliance Boots Annual Report 2013/14 We are a leading international pharmacy-led health and beauty group. Our focus is on helping people look and feel their best. What’s inside Strategic review Our financial performance in 2013/14 01 Executive Chairman’s statement 02 Our mission, purpose and values 05 Our Group at a glance 06 Our business activities 08 Group strategy and objectives 10 Our markets and business environment 14 Our financial record 16 Business review: Overview 18 Health & Beauty Division 20 Pharmaceutical Wholesale Division 28 Other activities 34 Financial review 36 Performance measures 42 We are launching innovative Our people 43 new products tailored to meet Corporate social responsibility 46 customer needs page 12 Governance Boots much loved brands are Board of Directors 50 increasingly available across Board report on corporate governance 54 the world page 26 Board report on remuneration 56 Audit and risk committee report 59 Risk management 60 Consolidated financial statements Directors’ responsibilities statement 62 Statutory auditor’s report 63 Group income statement 64 Group statement of comprehensive income 64 Group statement of financial position 65 Group statement of changes in equity 66 Group statement of cash flows 67 Notes to the consolidated financial statements 68 Additional information Principal businesses, associates and joint ventures 120 Glossary of key terms 123 Alphega is expanding its Supporting the fight against pharmacy network cancer page 44 across Europe page 32 Alliance Boots | Annual Report 2013/14 01 Strategic review Our financial performance in 2013/14 Strategic review for the year ended 31 March 2014 Underlying profit attributable to equity shareholders increased by 18.5%.
    [Show full text]
  • Alliance Boots Preliminary Results Announcement for the Year Ended 31 March 2010
    Press release 17 May 2010 Alliance Boots Preliminary results announcement for the year ended 31 March 2010 “A strong performance delivering double digit growth in trading profit” Highlights: Group • Revenue, including share of associates and joint ventures, up 9.6% to £22.5 billion • EBITDA, including share of associates and joint ventures, up 9.2% to £1,360 million • Trading profit, including share of associates and joint ventures, up 12.7% to £1,074 million • Underlying profit (after tax) more than doubled to £602 million • Cash generated from operations £1,130 million • Net borrowings reduced by £645 million Health & Beauty Division • Revenue up 5.2% – up 4.5% in constant currency • Trading profit up 8.5% • Boots UK - Like for like retail revenue up 3.0% - ‘your local Boots pharmacy’ roll-out completed - No7 Protect & Perfect Intense Beauty Serum launched • Boots Opticians merged with Dollond & Aitchison Pharmaceutical Wholesale Division • Revenue up 10.3% – up 5.6% in constant currency • Trading profit up 17.2% • Business improvement programme largely completed • Further selective deals with manufacturers Stefano Pessina, Executive Chairman, commented: “Since taking the company private, this is our third consecutive year of double digit trading profit growth. Having invested more than £1 billion over the period, we are confident that we are building a platform for sustained long term growth. “Our strong financial position will enable us to continue to grow both organically and through acquisitions. We are increasingly establishing strategic partnerships with other leading businesses to accelerate our development, both in the UK and other markets.” Andy Hornby, Group Chief Executive, said: “Alliance Boots performed strongly in 2009/10, delivering a double digit trading profit growth, combined with a robust cash flow.
    [Show full text]
  • At the Heart of Health Corporate Social Responsibility Report
    2020 At the Heart of Health Corporate Social Responsibility Report #WeAreWBA We are a leading global pharmacy retailer and wholesaler. As a health and well-being enterprise our purpose is to help people across the world lead healthier and happier lives. At the Heart of Health is our annual Corporate Social Responsibility report, covering our CSR initiatives, sustainability progress and Environmental, Social and Governance (ESG) performance for the fiscal year ended Aug. 31, 2020. OVERVIEW HEALTHY PLANET Message from Our Leaders 4 Energy and Emissions 85 Q&A with Our CSR Committee Chair 6 Waste and Plastics 94 Our Vision, Purpose and Values 8 Case Study: Honeybees on Campus 100 At a Glance: WBA 9 SUSTAINABLE MARKETPLACE Highlights and Recognitions 10 Progress Dashboard 12 Sustainability Progress in Our Owned Brands 103 Our Approach to CSR 15 Sourcing 106 CSR Materiality 24 Ingredients, Materials and Traceability 111 Stakeholder Engagement 28 Packaging, Labeling and Transparency 114 Our Response to COVID-19 38 Case Study: Removing Plastics from Boots UK Gift Product Lines 117 Our Response to the Racial Equity Movement 46 Brands with Purpose 118 HEALTHY AND INCLUSIVE WORKPLACE HEALTHY COMMUNITIES Employee Health, Well-being and Safety 123 Access to Affordable and Quality Healthcare 51 Equal Opportunities 134 Health Education and Awareness 61 Case Study: Unconscious Bias Training 145 Opioid Abuse Prevention 70 Data Privacy and Information Security 146 Partnerships for Good: 71 APPENDICES Supporting People Living with Cancer 72 About This Report
    [Show full text]
  • News: Interview with Ornella Barra on Forbes Monaco
    THE NEXT BILLION DOLLAR SAFARI BUSINESS BILLION- A CASE FOR MONACO’S EU DEAL DOLLAR STARTUPS TRUMP UNCONSTRAINED THE $6 BILLION WEATHER WARS “I’ve always had an entrepreneurial mindset and curious att itude. This empowered me to envision pharmacy’s full potential.” SPECIAL ENTREPRENEURIAL WOMEN Over the Counter with Ornella Barra HOW THE COMMUNITY PHARMACIST TURNED M 31766 5 F : €9 RD DRUGSTORE MOGUL IS 00030 BREAKING THE GLASS 9.50 CEILING. 3 783176 609006 Benelux: AUGUST 2019 MONACO FEMALE ENTREPRENEURS THE PROFILE 42 43 RANKED LAST YEAR AS ONE OF THE MOST POWERFUL WOMEN IN BUSINESS OUTSIDE THE U.S., PHARMACIST ORNELLA BARRA FOUNDED A WHOLESALE BUSINESS IN 1984 THAT TWO YEARS LATER BECAME ITALY’S LEADING DRUG DISTRIBUTOR WHEN IT MERGED WITH ALLEANZA SALUTE ITALIA, HEADED BY STEFANO PESSINA. THE COUPLE’S GREAT CHEMISTRY HAS ENDURED OVER 35 YEARS AND BARRA IS NOW CO-COO OF THE WORLD’S LARGEST DRUGSTORE CHAIN, WALGREENS BOOTS ALLIANCE. OTHESE BOOTS ARE MADE FOR WALGREENS BY CELINA LAFUENTE DE LAVOTHA PHOTOTGRAPH BY THIERRY BEAUVILAIN OUVRARD AUGUST 2 019 FORBES MONACO ambitious drive, she knew her career options would be arra stepped into her co-COO role in today and we are right in the middle of this evolution. limited. She instead studied Pharmacy at the University of June 2016 and oversees Global Brands, The nature of medicines is changing, as we see with Genoa, then managed a local pharmacy before acquiring B Pharmaceutical Wholesale, the Retail the growing importance of pharmacogenetics [the one in her hometown in 1979. “I always wanted to build Pharmacy International businesses outside study of the role of the genome in drug response].” something important for myself and others.
    [Show full text]
  • Walgreens Boots Alliance, Inc. 2017 Annual Report
    PART I Item 1. Business Overview Walgreens Boots Alliance, Inc., a Delaware corporation (“Walgreens Boots Alliance”) is the first global, pharmacy-led health and wellbeing enterprise with sales of $118.2 billion in the fiscal year ended August 31, 2017. Our purpose is to help people across the world lead healthier and happier lives. Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination across the U.S. and Europe. Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 251 countries and employ more than 385,0001 people. The company is a global leader in pharmacy-led, health and wellbeing retail and, together with the companies in which it has equity method investments, has over 13,2001 stores in 111 countries as well as one of the largest global pharmaceutical wholesale and distribution networks, with over 3901 distribution centers delivering to more than 230,0002 pharmacies, doctors, health centers and hospitals each year in more than 201 countries. In addition, Walgreens Boots Alliance is one of the world’s largest purchasers of prescription drugs and many other health and wellbeing products. Our portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Soap & Glory, Liz Earle, Sleek MakeUP and Botanics. Our global brands portfolio is enhanced by our in-house product research and development capabilities. We seek to further drive innovative ways to address global health and wellness challenges.
    [Show full text]
  • Leading by Example Stefano Pessina Won the 2013 Clarity Search Retail Leader of the Year Award
    Sponsored by THE CLARITY SEARCH RETAIL LEADER OF THE YEAR Leading by example Stefano Pessina won the 2013 Clarity Search Retail Leader of the Year award. Tiffany Holland talks to the Alliance Boots executive chairman to find out why he’s ahead of the pack n first meeting, it’s easy Last year the self-made billionaire to guess that Stefano revealed that Alliance Boots would Pessina is an entrepre- be partnering with US drugstore Oneur. He wears the sort of chain Walgreens, which will even- sharp suits you’d expect of a billion- tually lead to a full merger. aire and his confident, composed It was one of the most remarkable air could calm any boardroom. business moves in years, as Alliance As the boss of Alliance Boots, Boots, which earned a trading profit one of the largest retailers in the UK of £1.2bn in the last financial year, and one of the biggest pharmaceuti- joined forces with Walgreens’ cal wholesalers in the world, he is empire of 8,000 stores. known for his serene demeanour – The US retailer generated an oper- something that was undoubtedly ating income of $3.5bn (£2.3bn) in useful last June when he brokered the same financial year. In June it the landmark retail deal of 2012. was revealed that Walgreens would But when Retail Week speaks to initially invest $6.7bn (£4.5bn) in him, the Italian businessman is in cash and stocks to acquire 45% high spirits, cracking jokes and equity in Alliance Boots, with a revelling in the recognition his view to merge within three years.
    [Show full text]
  • Building an Ethical Small Group (Chapter 9 of Meeting the Ethical Challenges of Leadership) Craig E
    Digital Commons @ George Fox University Faculty Publications - School of Business School of Business 2018 Building an Ethical Small Group (Chapter 9 of Meeting the Ethical Challenges of Leadership) Craig E. Johnson George Fox University, [email protected] Follow this and additional works at: https://digitalcommons.georgefox.edu/gfsb Part of the Business Commons, and the Ethics and Political Philosophy Commons Recommended Citation Johnson, Craig E., "Building an Ethical Small Group (Chapter 9 of Meeting the Ethical Challenges of Leadership)" (2018). Faculty Publications - School of Business. 94. https://digitalcommons.georgefox.edu/gfsb/94 This Article is brought to you for free and open access by the School of Business at Digital Commons @ George Fox University. It has been accepted for inclusion in Faculty Publications - School of Business by an authorized administrator of Digital Commons @ George Fox University. For more information, please contact [email protected]. Building a11 Ethical Small Group Cooperation is the thorough conviction that nobody can get there unless everybody gets there. -AUTHOR VIRGINIA BURDEN TOWER Never underestimate a minority. -BRITISH PRIME MINISTER WINSTON CHURCHILL WHAT'S AHEAD This chapter examines ethical leadership in the small-group context. To help create groups that brighten rather than darken the lives of participants, leaders must foster individual ethical accountability among group members, ensure ethical group interac­ tion, avoid moral pitfalls, and establish ethical relationships with
    [Show full text]
  • Annual Report 2019.Pdf
    Annual Report 2019 Contents Introduction Overview The Restaurant Group operates Highlights and priorities 01 over 650 restaurants and pub Strategic report restaurants. Its principal trading brands Chairman’s statement 04 Business review 05 are Wagamama, Frankie & Benny’s, Financial review 10 Chiquito and Coast to Coast. The Group Corporate social responsibility 14 also operates Pub restaurants and a Concessions business which trades Governance Corporate Governance report 20 principally at UK airports. Board of Directors 30 Audit Committee report 32 Nomination Committee report 37 Directors’ remuneration report 41 Directors’ report 56 Senior Management Risk Committee 58 Directors’ responsibility statements 60 Our brands Financial statements Independent auditor’s report 61 Consolidated income statement 71 Consolidated balance sheet 72 Consolidated statement of changes in equity 73 Consolidated cash flow statement 74 Notes to the consolidated accounts 75 Company balance sheet 112 Statement of changes in equity 113 Notes to the Company accounts 114 Group financial record 120 Glossary 121 Shareholder information 122 Overview Highlights and priorities Operating highlights • Delivering the benefits of the Wagamama transaction – Market-leading like-for-like (LFL) sales performance of +8.5% report Strategic – Cost synergies ahead of plan, site conversion programme well progressed – US Joint Venture (JV) established after year-end to facilitate capital-light growth plan • Growing our Pubs and Concessions businesses – Concessions LFL sales growth
    [Show full text]